Sponsor Pipeline

Mapi Pharma Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07185815 Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting… Schizophrenia Recruiting
NCT07563699 Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes… Diabete Type 2 Not Yet Recruiting
Disease Areas
Depression (1) Bipolar Disorder (1) Schizophrenia (1)
Get alerts when Mapi Pharma Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free